American Association for Cancer Research

Bibliography

• BOON T, CEROTTINI JC, VAN DEN EYNDE B, VAN DER BRUGGEN P, VAN PEL A: Tunaor antigens recognized by T lymphocytes. Ann. Rev. Immunol. (1994) 12:337–365.
   PubMed Web of Science ®Google Scholar
• •A comprehensive review of immunologically relevant tumour targets.
   Google Scholar
• ROSENBERG SA: Principles of Cancer Management: biologic therapy. In: Cancer: Principles and Practice of Oncology, 5th edition. De Vita VT, Hellman S and Rosenberg SA (Eds). Lippincott-Raven Publishers, Philadelphia, USA 349–373.
   Google Scholar
• ••This book chapter provides a good background on the basicprinciples of tumour immunology. A highly recommended read for both immunologists and clinical oncologists.
   Google Scholar
• EVANS EE, SMITH E, LUHOWSKYJ S, MUELER L, ZAUDERER M SAHASRABUDHE DM: Identification of human tumor antigen candidates using subtractive hybridization. Proc. Am. Assoc. Cancer Res. (2000) 41:879 (Abstract 5584).
   Google Scholar
• ZENDMAN AJW, CORNELISSEN IMHA, WEIDLE UH,RUITER DJ, MUIJEN GNP: Characterization of CTP11, a novel member of the family of cancer/testis antigens. Proc. Am. Assoc. Cancer Res. (2000) 41:879 (Abstract 5588).
   Google Scholar
• AN G, MEKA CSR, NG AY et al.: UROC41: a novel gene over expressed in prostate cancer. Proc. Am. Assoc. Cancer Res. (2000) 41:41 (Abstract 260).
   Google Scholar
• CHAIB H, RUBIN MA, MUCCI NR, RHIM JS, MACOSKA JA: Isolation and characterization of AIPC, a PDZ domain-containing protein highly expressed in human primary prostate tumors. Proc. Am. Assoc. Cancer Res. (2000) 41:318 (Abstract 2020).
   Google Scholar
• ASHOK B, CHEN Y, YADAVELLI S, NORONHA J,MITELMAN A, TIWARI RK: Identification of prostate cancer associated immunogens using synthetic combinatorial single chain (SCFV) phage display antibody library. Proc. Am. Assoc. Cancer Res. (2000) 41:698 (Abstract 4441).
   Google Scholar
• BLOEMENDAL HJ, VAN WOLFSWINKEL A, GEBBINKMFBG, LOGTENBERG T, VOEST EE: Identification of tumor endothelial cell-associated antigens with phage display technology. Proc. Am. Assoc. Cancer Res. (2000) 41:699 (Abstract 4445).
   Google Scholar
• SAHIN U, TURECI O, SCHMITT H et al.: Human neoplasms elicit multiple immune responses in the autologous host. Proc. Natl. Acad. Sci. USA (1995) 92:11810–11813.
   PubMed Web of Science ®Google Scholar
• •Initial demonstration of the SEREX technique.
   Google Scholar
• TODA M, LIZUKA Y, TAKAHASHI S et al.: Identification and characterization of human brain tumor antigens: a potential target for specific irnnaunotherapy and diagnostic marker. Proc. Am. Assoc. Cancer Res. (2000) 41:710 (Abstract 4513)•
   Google Scholar
• TAKAHASHI S, TODA M, LIZUKA Y, YOSHIDA K, KAWASET, KAWAKAMI Y: Characterization of tumor antigens recognized by IgG antibody in patients with glioma using SEREX. Proc. Am. Assoc. Cancer Res. (2000) 41:880 (Abstract 5590).
   Google Scholar
• SEGAL NH, BLACHERE NE, HOUGHTON AN, LEWIS JJ: The identification of antigens in soft tissue sarcoma. Proc. Am. Assoc. Cancer Res. (2000) 41:697 (Abstract 4433).
   Google Scholar
• DE PLAEN E, LURQUIN C, VAN PEL A et al.: Immunogenic (turn-) variants of mouse P815. Cloning of the gene of tuna- antigen P91A and identification of the tum-mutation. Proc. Natl. Acad. Sci. USA (1988) 85:2274–2278.
   Google Scholar
• •First demonstration of the TREX technique.
   Google Scholar
• VAN DER BRUGGEN P, TRAVERSARI C, CHOMEZ P et al.: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (1991) 254:1643–1647.
   Google Scholar
• ••A pioneering work describing the isolation of a melanomaantigen recognised by cytotoxic T cells.
   Google Scholar
• KARANIKAS V, WEYNANTS P, BAURAIN JF et al.: A mutation in the maw enzyme gene generates an antigen recognized by anti-tumor CTL of a lung carcinoma patient with long survival. Proc. Am. Assoc. Cancer Res. (2000) 41:698 (Abstract 4439).
   Google Scholar
• CHANG H, KIM W, PARK J et al.: The expressions and their implications of cancer/testis antigens in uterine cervical carcinoma. Proc. Am. Assoc. Cancer Res. (2000) 41:880 (Abstract 5589)•
   Google Scholar
• HANRAHAN CF, DE MARZO AM, ZHONG H et al.: Overex-pression of hypoxia-inducible factor 1 in high-grade prostatic intraepithelial neoplasia. Proc. Am. Assoc. Cancer Res. (2000) 41:39 (Abstract 252).
   Google Scholar
• SASATOMI T, YANG D, MIYAGI Y et al.: Expression of thetumor-rejection antigen SART3 in colorectal cancers. Proc. Am. Assoc. Cancer Res. (2000) 41:709 (Abstract 4509).
   Google Scholar
• SARKAR AK, NUCHTERN JG: Identification of HLA-A24 MYCN peptide capable of inducing MHC-restricted lysis of MYCN amplified neuroblastoma cells. Proc. Am. Assoc. Cancer Res. (2000) 41:697 (Abstract 4430).
   Google Scholar
• GILBOA E: The makings of a tumor rejection antigen. Immunity (1999) 11:263–270.
   PubMed Web of Science ®Google Scholar
• ••An excellent review of tumour antigens and their character-istics most suitable for cancer immunotherapy.
   Google Scholar